Adamis Pharmaceuticals | ADMP - Ebitda



Ebitda Veränderung Datum
Adma Biologics USD 73.59M 14.85M 2025-12
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 3.13B 1.17B 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Merck USD 8.39B 1.97B 2025-09
Pfizer USD 6.08B 351M 2025-09
RedHill Biopharma USD 2.69M 108.46M 2023-06